Clinical Trial Update: Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of insulin in patients with Type 1 diabetes has completed. The study was sponsored by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED